acetylcysteine has been researched along with Cancer of Pituitary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Melmed, S; Ren, SG; Yu, R | 1 |
| Atkin, SL; Burgoyne, CH; Drummond, N; Newton, CJ; Speirs, V; Stalla, GK | 1 |
2 other study(ies) available for acetylcysteine and Cancer of Pituitary
| Article | Year |
|---|---|
Proteasome inhibitors induce apoptosis in growth hormone- and prolactin-secreting rat pituitary tumor cells.
Topics: Acetylcysteine; Animals; Apoptosis; Blotting, Western; Caspases; Cells, Cultured; Cysteine Endopeptidases; Enzyme Activation; Enzyme Inhibitors; Female; Growth Hormone; In Situ Nick-End Labeling; Leupeptins; Multienzyme Complexes; Pituitary Gland, Anterior; Pituitary Neoplasms; Prolactinoma; Proteasome Endopeptidase Complex; Rats; Tumor Cells, Cultured | 2002 |
Functional inactivation of the oestrogen receptor by the antioestrogen, ZM 182780, sensitises tumour cells to reactive oxygen species.
Topics: Acetylcysteine; Animals; Antineoplastic Agents; Antioxidants; Cell Death; DNA Fragmentation; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Fulvestrant; Hydrogen Peroxide; Membrane Potentials; Mitochondria; Pituitary Neoplasms; Rats; Reactive Oxygen Species; Receptors, Estrogen; Tumor Cells, Cultured | 1999 |